Meeting
2023 ASCO Gastrointestinal Cancers Symposium
A randomized, multi-center phase III trial of adjuvant chemotherapy with gemcitabine and capecitabine (GemCap) compared to capecitabine (Cap) alone in curatively resected biliary tract cancer (BilGemCap Study): KCSG HB20-14.
Authors
Joon Oh Park
Samsung Medical Center, Seoul, South Korea;
Joon Oh Park , Joon Seong Park , Choong-kun Lee , Hong Jae Chon , Sae Byeol Choi , Dae Wook Hwang , Do-Youn Oh , Myung Ah Lee , Jin-Young Jang , Baek-Yeol Ryoo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT0005056
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr TPS633)
DOI
10.1200/JCO.2023.41.4_suppl.TPS633
Abstract #
TPS633
Poster Bd #
P2
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Characterizing outcomes of ERBB2-amplified biliary tract cancer.
First Author: Daniel Aaron Fox
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Outcomes by antibiotic use in participants with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study.
First Author: Aiwu He
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Clinical relevance of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma who underwent surgery following neoadjuvant modified FOLFIRINOX.
First Author: So Heun Lee
Poster
2020 Gastrointestinal Cancers Symposium
Circulating tumor DNA-based decision for adjuvant treatment in colon cancer stage II evaluation: (CIRCULATE-trial) AIO-KRK-0217.
First Author: Gunnar Folprecht